These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 26796669)

  • 1. CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
    Wang G; Zhao N; Berkhout B; Das AT
    Mol Ther; 2016 Mar; 24(3):522-6. PubMed ID: 26796669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.
    Zhao N; Wang G; Das AT; Berkhout B
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed
    Ophinni Y; Miki S; Hayashi Y; Kameoka M
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA.
    Binda CS; Klaver B; Berkhout B; Das AT
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32197474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures.
    Wang G; Zhao N; Berkhout B; Das AT
    Cell Rep; 2016 Dec; 17(11):2819-2826. PubMed ID: 27974196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas based antiviral strategies against HIV-1.
    Wang G; Zhao N; Berkhout B; Das AT
    Virus Res; 2018 Jan; 244():321-332. PubMed ID: 28760348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.
    Yoder KE; Bundschuh R
    Sci Rep; 2016 Jul; 6():29530. PubMed ID: 27404981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.
    Yuen KS; Wang ZM; Wong NM; Zhang ZQ; Cheng TF; Lui WY; Chan CP; Jin DY
    Virus Res; 2018 Jan; 244():296-303. PubMed ID: 28456574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion/deletion profiles.
    Lemos BR; Kaplan AC; Bae JE; Ferrazzoli AE; Kuo J; Anand RP; Waterman DP; Haber JE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2040-E2047. PubMed ID: 29440496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.